Show simple item record

dc.contributor.authorFerolla, P
dc.contributor.authorBrizzi, M
dc.contributor.authorMeyer, T
dc.contributor.authorMansoor, Was
dc.contributor.authorMazieres, J
dc.contributor.authorCao, C
dc.contributor.authorLena, H
dc.contributor.authorBerruti, A
dc.contributor.authorDamiano, V
dc.contributor.authorBuikhuisen, W
dc.contributor.authorStankovic, M
dc.contributor.authorSingh, N
dc.contributor.authorChiodini, E
dc.contributor.authorGislimberti, G
dc.contributor.authorOberg, K
dc.contributor.authorBaudin, E
dc.date.accessioned2017-05-02T19:48:16Z
dc.date.available2017-05-02T19:48:16Z
dc.date.issued2016-10-01
dc.identifier.citationEfficacy and safety of pasireotide LAR or everolimus alone, or in combination in patients with advanced carcinoids (NET) of the lung/thymus: results from the randomized, phase 2 LUNA study. 2016, 27(suppl 6):4160 Annals of Oncologyen
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.doi10.1093/annonc/mdw369.01
dc.identifier.urihttp://hdl.handle.net/10541/620308
dc.language.isoenen
dc.relation.urlhttps://academic.oup.com/annonc/article/2799155/Efficacyen
dc.rightsArchived with thanks to Annals of Oncologyen
dc.titleEfficacy and safety of pasireotide LAR or everolimus alone, or in combination in patients with advanced carcinoids (NET) of the lung/thymus: results from the randomized, phase 2 LUNA study.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDept. of Medical Oncology, Multidisciplinary NET Group, Umbria Regional Cancer Network and University of Perugia, Perugiaen
dc.identifier.journalAnnals of Oncologyen


This item appears in the following Collection(s)

Show simple item record